Judge Won't Toss $100M Trade Secret Suit Against Akorn

Law360, New York (July 30, 2013, 7:00 PM EDT) -- A New York federal judge Monday denied generic-drug maker Akorn Inc.'s argument that a $100 million trade secrets and breach of contract suit filed by Fera Pharmaceuticals LLC was barred by the companies' supply agreement, ruling the agreement might have been induced by fraud, and therefore invalid.

U.S. District Judge Louis Stanton said those provisions of the contract between Akorn and Fera, its distributor, limiting the parties’ right to sue and imposing a two-year limit on their ability to bring claims "fall with the rest of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

FERA Pharmaceuticals, LLC v. Akorn, Inc. et al


Case Number

1:12-cv-07694

Court

New York Southern

Nature of Suit

Contract: Other

Judge

Louis L. Stanton

Date Filed

October 15, 2012

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.